Blood protein fingerprint may reveal lung disease secrets

NCT ID NCT00793676

Completed Knowledge-focused Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a family of proteins called GPCRs, found on the surface of cells, can be used as biomarkers to diagnose or track chronic lung diseases like asthma and COPD. Researchers analyzed blood samples from 205 people (healthy volunteers and patients) to see if the GPCR profile changes with disease. The goal is to create a GPCR "identity card" for each disease, which could help doctors monitor disease progression or treatment effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma chronic obstructive pulmonary disease COPD, severe early onset disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA COPD

Contacts and locations

Locations

Antoine Magnan

Nantes, 44035, France
Hospital

Colmar, 68024, France
Pascal Chanez

Marseille, 13008, France
University Hospital

Montpellier, 34295, France
University Hospital, Strasbourg, France

Strasbourg, 67000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.